Freenome logo

Freenome Holdings, Inc.


Freenome Stock

Freenome is a biotechnology company focused on developing blood tests for the early detection of cancer. Its multiomics platform integrates data from genomics, proteomics, and other biological sources to identify cancer at its earliest stages through a simple blood draw.

Founded: 2014

Freenome Website

Management Team

Mike Nolan Chief Executive Officer
Riley Ennis Co-Founder and Chief Product Officer
Greg Chow Chief Financial Officer
Jimmy Lin, M.D., Ph.D. Chief Scientific Officer
Julie Tran Chief People Officer
Lance Baldo, M.D. Chief Medical Officer
Michael Ash Chief Commercial Officer

Funding Information